General Information of the Compound
| Compound ID |
CP0969843
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-2-(((2S,3S,4S)-3,4-Dihydroxy-6-(((4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)benzyl)amino)-methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-((2S,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxy-4-methoxytetrahydrofuran-2-yl)acetamide
Show/Hide
|
||||||||||||||||||
| Formula |
C36H42F3N5O12
|
||||||||||||||||||
| Molecular Weight |
793.749
|
||||||||||||||||||
| Canonical SMILES |
CO[C@@H]1[C@H](O)[C@@H]([C@@H](O[C@H]2OC(CNCc3ccc(N4CCC(Oc5ccc(OC(F)(F)F)cc5)CC4)cc3)=C[C@H](O)[C@@H]2O)C(N)=O)O[C@H]1n1ccc(=O)[nH]c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H42F3N5O12/c1-51-30-28(48)29(54-33(30)44-15-12-26(46)42-35(44)50)31(32(40)49)55-34-27(47)25(45)16-24(53-34)18-41-17-19-2-4-20(5-3-19)43-13-10-22(11-14-43)52-21-6-8-23(9-7-21)56-36(37,38)39/h2-9,12,15-16,22,25,27-31,33-34,41,45,47-48H,10-11,13-14,17-18H2,1H3,(H2,40,49)(H,42,46,50)/t25-,27-,28+,29-,30+,31+,33+,34+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QMVGNCUEQWZQQF-DAWACNMHSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound